Literature DB >> 15235900

Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.

Nicolas Penel1, Charles Fournier, Micheline Roussel-Delvallez, Danièle Lefebvre, Ahmed Kara, Yann Mallet, Jean-Charles Neu, Jean-Louis Lefebvre.   

Abstract

OBJECTIVE: We evaluated the incidence, risk factors and consequences of wound infection (WI) following major head and neck cancer surgery in an open non-comparative study. PATIENTS AND METHODS: The study group, comprising 95 patients who underwent clean-contaminated procedures with opening of the upper aerodigestive tract for biopsy-proven squamous cell cancer, were studied over a 1-year period. Antibiotic prophylaxis was amoxicillin and clavulanic acid. More than 20 variables were prospectively recorded for each patient. The mean follow-up was 30 months. MAIN
RESULTS: The overall WI rate was 50.5% (48/95). Most pathogens isolated from samples were gram-negative rods. In univariate analysis, we found three risk factors for WI: alcohol consumption (P = 0.07), a hypopharyngeal location (P = 0.02) and laryngectomy stoma (P = 0.01). WI were associated with postoperative fever (P = l.5 x 10(-11)), postoperative antibiotic therapy (P = 1.5 x 10(-5)) and postoperative death (P = 0.043). Patients without WI had a median postoperative hospital stay of 15 days compared with 29 days for those with WI (P < 0.001). Healing of WI was achieved after a median time of 48 days. WI delayed postoperative radiation therapy in 21 out of 33 evaluable patients. But overall survival, and local and metastatic failures were similar with and without WI.
CONCLUSIONS: WI are associated with a heavy postoperative morbidity, but have no prognostic impact on cancer control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15235900     DOI: 10.1007/s00520-004-0600-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  33 in total

1.  Medical complications in total laryngectomy: incidence and risk factors.

Authors:  M A Arriaga; K T Kanel; J T Johnson; E N Myers
Journal:  Ann Otol Rhinol Laryngol       Date:  1990-08       Impact factor: 1.547

2.  Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery.

Authors:  M Righi; R Manfredi; G Farneti; E Pasquini; V Cenacchi
Journal:  Head Neck       Date:  1996 Sep-Oct       Impact factor: 3.147

3.  The role of bacterial interference in the increased prevalence of oropharyngeal gram-negative bacilli among alcoholics and diabetics.

Authors:  P A Mackowiak; R M Martin; J W Smith
Journal:  Am Rev Respir Dis       Date:  1979-09

4.  Risk of wound infection in patients with head and neck cancer.

Authors:  K T Robbins; S Favrot; D Hanna; R Cole
Journal:  Head Neck       Date:  1990 Mar-Apr       Impact factor: 3.147

5.  Cefotaxime in the prophylaxis of otorhinolaryngological cancer surgery. Long term versus short term administration, results of a multicentre study.

Authors:  P Gehanno; N Moisy; C Guédon
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Cefazolin prophylaxis in head and neck cancer surgery.

Authors:  G D Becker; G J Parell
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Mar-Apr       Impact factor: 1.547

7.  One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery.

Authors:  W E Fee; M Glenn; C Handen; M L Hopp
Journal:  Laryngoscope       Date:  1984-05       Impact factor: 3.325

8.  Antimicrobial prophylaxis for contaminated head and neck surgery.

Authors:  J T Johnson; E N Myers; P B Thearle; B A Sigler; V L Schramm
Journal:  Laryngoscope       Date:  1984-01       Impact factor: 3.325

9.  Identifying high-risk patients before head and neck oncologic surgery.

Authors:  B T Pelczar; H G Weed; D E Schuller; D C Young; T E Reilley
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-08

10.  Antimicrobial prophylaxis of infections in head and neck cancer surgery.

Authors:  M Piccart; P Dor; J Klastersky
Journal:  Scand J Infect Dis Suppl       Date:  1983
View more
  7 in total

1.  Factors contributing to surgical site infection in patients with oral cancer undergoing microvascular free flap reconstruction.

Authors:  Sheng-Chiao Lin; Ting-Shou Chang; Kuo-Chung Yang; Yaoh-Shiang Lin; Yu-Hsuan Lin
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-09       Impact factor: 2.503

2.  Surgical site infection in clean-contaminated head and neck cancer surgery: risk factors and prognosis.

Authors:  Hitoshi Hirakawa; Yasuhisa Hasegawa; Nobuhiro Hanai; Taijiro Ozawa; Ikuo Hyodo; Mikio Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-04       Impact factor: 2.503

3.  Factors affecting wound complications in head and neck surgery: A prospective study.

Authors:  Devendra A Chaukar; Anuja D Deshmukh; Tanveer Majeed; Pankaj Chaturvedi; Prathamesh Pai; Anil K D'cruz
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

4.  Postoperative abnormal response of C-reactive protein as an indicator for infectious complications after oral oncologic surgery with primary reconstruction.

Authors:  Masaya Akashi; Shungo Furudoi; Kazunobu Hashikawa; Akiko Sakakibara; Takumi Hasegawa; Takashi Shigeta; Tsutomu Minamikawa; Takahide Komori
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-04-02

Review 5.  Evidence and evidence gaps of laryngeal cancer surgery.

Authors:  Susanne Wiegand
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

6.  Povidone-Iodine Irrigation of Subcutaneous Tissues May Decrease Surgical Site Infections in Elective Colorectal Operations: A Systematic Review.

Authors:  Richdeep S Gill; David P Al-Adra; Sandy Campbell; David W Olson; Brian H Rowe
Journal:  Gastroenterology Res       Date:  2011-05-20

7.  Clinical application of decellularized and lyophilized human amnion/chorion membrane grafts for closing post-laryngectomy pharyngocutaneous fistulas.

Authors:  Zurab Kakabadze; Konstantine Mardaleishvili; George Loladze; Ivane Javakhishvili; Konstantine Chakhunasvili; Lika Karalashvili; Natia Sukhitashvili; Gocha Chutkerashvili; Ann Kakabadze; David Chakhunasvili
Journal:  J Surg Oncol       Date:  2016-01-21       Impact factor: 3.454

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.